Oral Answers to Questions

Christian Matheson Excerpts

Tuesday 29th October 2019 Commons Chamber

[Edward Argar]

The hon. Lady will know that the plans that will be brought forward will be clinically led and delivered and constructed by the trust itself, so I would encourage her to engage with the trust and with neighbouring trusts, but surely she would welcome this significant investment by the Government in her health infrastructure.

[Christian Matheson (City of Chester) (Lab)]

3. What steps he is taking to help ensure access to Orkambi on the NHS.

[Kerry McCarthy (Bristol East) (Lab)]

4. What progress has been made in enabling the provision of Orkambi on the NHS.

[The Secretary of State for Health and Social Care (Matt Hancock)]

I am delighted that a deal has been agreed to provide Orkambi and other cystic fibrosis drugs on the NHS. This deal is great value for the NHS and backed by the National Institute for Health and Care Excellence, but crucially it will improve thousands of lives. My heartfelt thanks go out to many campaigners from right across the House who have pushed this agenda but especially to the Cystic Fibrosis Trust and the patients who, along with their families, have bravely campaigned against this devastating disease. I am thrilled that we can make this progress.

[Christian Matheson]

It may have taken a few years, but I warmly welcome the Secretary of State’s announcement and congratulate him on it. I echo his congratulations to all the campaigners, particularly my hon. Friend the Member for Dudley North (Ian Austin), who has led much of the campaign.

Ten per cent. of cystic fibrosis sufferers are still waiting for approval for another critical combination therapy, called Elexacaftor. Can the Secretary of State reassure me that eligible patients will not have to wait so long for that to be approved?

[Matt Hancock]

Of course I would have liked the deal to happen sooner, but I am glad that the company has now committed itself to engaging properly in the normal processes which mean that we obtain drugs nearly as fast as any country in the world. This result—this deal—shows that the system is working to get cutting-edge drugs into the NHS at good value for the NHS pound.

I join the hon. Gentleman in paying tribute to the hon. Member for Dudley North (Ian Austin). I also pay tribute to the hon. Member for Bristol East (Kerry McCarthy), and to other Members in all parts of the House who have campaigned on this issue. It is great to have made some progress.